Navigation Links
New FDA Approved Drug NATRECOR For Heart Failure Patients

The US government has approved a genetically engineered drug called NATRECOR to ease the breathing of hospitalized congestive heart failure patients.

Congestive heart failure is a condition // in which the heart can't pump enough blood to meet the needs of the body's other organs. Most of the patients with congestive heart failure suffer flare-ups in which they gasp for breath and need hospitalization.

The U.S. Food and Drug Administration approved an injection of Natrecor as a way to treat these acute flare-ups. Natrecor, known chemically as nesiritide, is a biologically engineered version of a natural hormone that helps dilate blood vessels. That dilation helps blood flow from the weakened heart. But it also can cause seriously low blood pressure.

Two years ago, the FDA rejected approval of Natrecor because it caused so many cases of hypotension rates of 8 percent to 14 percent, depending on the dose used. Hence studies were conducted in another study group of 498 patients with a much smaller dose. This time, low blood pressure struck only about 4 percent of patients. So the FDA approved an injection containing the lower Natrecor dose.

Studies showed patients could breathe better as blood circulation and lung congestion improved with Natrecor treatment. California-based Scios Pharmaceuticals said it will start shipping Natrecor to hospitals this week and each vial, a day's treatment, will cost $380.


'"/>




Page: 1

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New Oral Rinse For Gingivitis Approved By FDA
4. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
5. AIDS Generic Drugs Approved by FDA for Sale in US
6. FDA Approved Nerve-Stimulation Therapy Now Available In New York
7. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
8. Pfizer’s Eraxis Approved By The FD
9. Inhalers for Kids Was Approved By the FDA
10. Alcoholism Drug Vivitrol Approved By FDA
11. Drug Approved to Curb Alcohol Dependency
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... ... The Pierre Hotel in New York, NY, on December 3rd, to benefit Holy ... physicians attended the annual event, which raised over $1 million - the largest ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand ... “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... version gives development continuity to its innovative Unified Instance Manager architecture, meeting ... In addition, this new version optimizes the unattended auto-dialing system without agents, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Mich. , Dec. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: ... as a 2016 Top Workplaces National Standard. ... ... Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ... based on an employee survey administered by WorkplaceDynamics, LLC, a research ...
(Date:12/8/2016)... Connecticut , 8 de dezembro de 2016  A Mederi Therapeutics ... terapia Stretta, um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and ... of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
Breaking Medicine Technology: